{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:27:41Z","timestamp":1792985261492,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008848","name":"Elitenetzwerk Bayern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019697","name":"Plexxikon Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.expneurol.2022.114195","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T11:23:43Z","timestamp":1659439423000},"page":"114195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Presymptomatic macrophage targeting has a long-lasting therapeutic effect on treatment termination in a mouse model of Charcot-Marie-Tooth 1"],"prefix":"10.1016","volume":"357","author":[{"given":"Charlotte","family":"Ostertag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2022.114195_bb0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/intimm\/dxaa030","article-title":"The origin, fate and function of macrophages in the peripheral nervous system - an update","volume":"32","author":"Amann","year":"2020","journal-title":"Int. Immunol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0010","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1523\/JNEUROSCI.17-12-04545.1997","article-title":"Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32","volume":"17","author":"Anzini","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114195_bb0015","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.4103\/1673-5374.253520","article-title":"Compartmentalized necroptosis activation in excitotoxicity-induced axonal degeneration: a novel mechanism implicated in neurodegenerative disease pathology","volume":"14","author":"Arrazola","year":"2019","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.expneurol.2022.114195_bb0020","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1007\/s13311-021-01125-3","article-title":"Lessons from injury: how nerve injury studies reveal basic biological mechanisms and therapeutic opportunities for peripheral nerve diseases","volume":"18","author":"Arthur-Farraj","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2022.114195_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00684538","article-title":"Cellular uptake of exogenous horseradish peroxidase in mouse peripheral nerve","volume":"37","author":"Arvidson","year":"1977","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0030","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1007\/s00415-019-09453-3","article-title":"Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype","volume":"266","author":"Callegari","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1083\/jcb.152.2.301","article-title":"The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0","volume":"152","author":"Carenini","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/bs.ctdb.2016.10.004","article-title":"Regulation of embryonic and postnatal development by the CSF-1 receptor","volume":"123","author":"Chitu","year":"2017","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-020-01822-4","article-title":"Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis","volume":"17","author":"Christoforidou","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2022.114195_bb0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41583-020-0269-3","article-title":"Programmed axon degeneration: from mouse to mechanism to medicine","volume":"21","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114195_bb0055","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1523\/JNEUROSCI.10-06-01855.1990","article-title":"Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions","volume":"10","author":"de Waegh","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114195_bb0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jnr.490300121","article-title":"Local control of axonal properties by Schwann cells: neurofilaments and axonal transport in homologous and heterologous nerve grafts","volume":"30","author":"de Waegh","year":"1991","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2022.114195_bb0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(92)90183-D","article-title":"Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells","volume":"68","author":"de Waegh","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2022.114195_bb0070","article-title":"Macrophage depletion blocks congenital SARM1-dependent neuropathy","author":"Dingwall","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.expneurol.2022.114195_bb0075","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","article-title":"Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain","volume":"82","author":"Elmore","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2022.114195_bb0080","doi-asserted-by":"crossref","first-page":"e12832","DOI":"10.1111\/acel.12832","article-title":"Replacement of microglia in the aged brain reverses cognitive, synaptic, and neuronal deficits in mice","volume":"17","author":"Elmore","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.expneurol.2022.114195_bb0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.mcn.2007.02.014","article-title":"Visualization of degenerating axons in a dysmyelinating mouse mutant with axonal loss","volume":"35","author":"Ey","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114195_bb0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.expneurol.2022.114195_bb0095","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.mcn.2007.10.012","article-title":"Monocyte chemoattractant protein-1 is a pathogenic component in a model for a hereditary peripheral neuropathy","volume":"37","author":"Fischer","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114195_bb0100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/bmb\/lds010","article-title":"Murine therapeutic models for Charcot-Marie-tooth (CMT) disease","volume":"102","author":"Fledrich","year":"2012","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.expneurol.2022.114195_bb0105","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/s41467-019-09385-6","article-title":"NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies","volume":"10","author":"Fledrich","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2022.114195_bb0110","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1007\/s13311-021-01145-z","article-title":"Mechanisms and treatments in demyelinating CMT","volume":"18","author":"Fridman","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2022.114195_bb0115","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1742-2094-8-110","article-title":"Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury","volume":"8","author":"Gaudet","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2022.114195_bb0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.conb.2016.05.002","article-title":"Axon degeneration: context defines distinct pathways","volume":"39","author":"Geden","year":"2016","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0125","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0092-8674(92)90591-Y","article-title":"Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons","volume":"71","author":"Giese","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2022.114195_bb0130","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1093\/hmg\/ddq269","article-title":"Attenuation of MCP-1\/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X","volume":"19","author":"Groh","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2022.114195_bb0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/brain\/awr283","article-title":"Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-tooth disease type 1X","volume":"135","author":"Groh","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2022.114195_bb0140","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/glia.22796","article-title":"CSF-1-activated macrophages are target-directed and essential mediators of schwann cell dedifferentiation and dysfunction in Cx32-deficient mice","volume":"63","author":"Groh","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2022.114195_bb0145","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1523\/JNEUROSCI.3427-15.2016","article-title":"Cell-surface and secreted isoforms of CSF-1 exert opposing roles in macrophage-mediated neural damage in Cx32-deficient mice","volume":"36","author":"Groh","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114195_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.703532","article-title":"A novel NAD signaling mechanism in axon degeneration and its relationship to innate immunity","volume":"8","author":"Hopkins","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.expneurol.2022.114195_bb0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/jns.12452","article-title":"Loss of function MPZ mutation causes milder CMT1B neuropathy","volume":"26","author":"Howard","year":"2021","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2022.114195_bb0160","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41593-018-0090-8","article-title":"Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion","volume":"21","author":"Huang","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114195_bb0165","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41434-021-00250-0","article-title":"AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy","volume":"28","author":"Kagiava","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2022.114195_bb0170","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2015.11.033","article-title":"Myelin and macrophages in the PNS: an intimate relationship in trauma and disease","volume":"1641","author":"Klein","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2022.114195_bb0175","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1093\/brain\/awv240","article-title":"Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice","volume":"138","author":"Klein","year":"2015","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113786","article-title":"Physical exercise mitigates neuropathic changes in an animal model for Charcot-Marie-Tooth disease 1X","volume":"343","author":"Klein","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0185","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/glia.24158","article-title":"Early targeting of endoneurial macrophages alleviates the neuropathy and affects abnormal Schwann cell differentiation in a mouse model of Charcot-Marie-Tooth 1A","volume":"70","author":"Klein","year":"2022","journal-title":"Glia."},{"key":"10.1016\/j.expneurol.2022.114195_bb0190","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.2353\/ajpath.2010.090694","article-title":"MCP-1\/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot-Marie-Tooth 1A neuropathy","volume":"176","author":"Kohl","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4049\/jimmunol.1901077","article-title":"Origin and differentiation of nerve-associated macrophages","volume":"204","author":"Kolter","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chembiol.2019.11.002","article-title":"Emergence of SARM1 as a potential therapeutic target for Wallerian-type diseases","volume":"27","author":"Loring","year":"2020","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.expneurol.2022.114195_bb0205","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1093\/brain\/awy280","article-title":"Development and validation of the Charcot-Marie-tooth disease infant scale","volume":"141","author":"Mandarakas","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2022.114195_bb0210","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ajpath.2013.06.002","article-title":"Similarities between inherited demyelinating neuropathies and Wallerian degeneration: an old repair program may cause myelin and axon perturbation under nonlesion conditions","volume":"183","author":"Martini","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2010.12.006","article-title":"The Wlds transgene reduces axon loss in a Charcot-Marie-tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration","volume":"42","author":"Meyer Zu Horste","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2022.114195_bb0220","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/brain\/awn332","article-title":"Motor axon excitability during Wallerian degeneration","volume":"132","author":"Moldovan","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2022.114195_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146539","article-title":"Targeting the programmed axon degeneration pathway as a potential therapeutic for Charcot-Marie-Tooth disease","volume":"1727","author":"Moss","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2022.114195_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135595","article-title":"New evidence for secondary axonal degeneration in demyelinating neuropathies","volume":"744","author":"Moss","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2022.114195_bb0235","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/jns.12483","article-title":"SARM1 knockout does not rescue neuromuscular phenotypes in a Charcot-Marie-tooth disease type 1A mouse model","volume":"27","author":"Moss","year":"2022","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2022.114195_bb0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12974-022-02454-6","article-title":"The macrophage: a key player in the pathophysiology of peripheral neuropathies","volume":"19","author":"Msheik","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2022.114195_bb0245","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/S0002-9440(10)63070-2","article-title":"Rapid response of identified resident endoneurial macrophages to nerve injury","volume":"159","author":"Mueller","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0250","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.LAB.0000056993.28149.BF","article-title":"Macrophage response to peripheral nerve injury: the quantitative contribution of resident and hematogenous macrophages","volume":"83","author":"Mueller","year":"2003","journal-title":"Lab. Investig."},{"key":"10.1016\/j.expneurol.2022.114195_bb0255","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.expneurol.2006.07.018","article-title":"Macrophage colony stimulating factor is a crucial factor for the intrinsic macrophage response in mice heterozygously deficient for the myelin protein P0","volume":"203","author":"Muller","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0260","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ydbio.2012.03.026","article-title":"The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation","volume":"367","author":"Nandi","year":"2012","journal-title":"Dev. Biol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0265","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nm.2324","article-title":"A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"17","author":"Nikic","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2022.114195_bb0270","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s40478-018-0636-8","article-title":"Forced turnover of aged microglia induces an intermediate phenotype but does not rebalance CNS environmental cues driving priming to immune challenge","volume":"6","author":"O'Neil","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.expneurol.2022.114195_bb0275","first-page":"11","article-title":"Challenges in treating charcot-marie-tooth disease and related neuropathies: current management and future perspectives","author":"Pisciotta","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/j.expneurol.2022.114195_bb0280","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/14737175.2021.1935242","article-title":"Updated review of therapeutic strategies for Charcot-Marie-Tooth disease and related neuropathies","volume":"21","author":"Pisciotta","year":"2021","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.expneurol.2022.114195_bb0285","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.nbd.2017.02.009","article-title":"Defective axonal transport: a common pathological mechanism in inherited and acquired peripheral neuropathies","volume":"105","author":"Prior","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2022.114195_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209752","article-title":"Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A)","volume":"14","author":"Prukop","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2022.114195_bb0300","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/brain\/awv395","article-title":"Immunosenescence of microglia and macrophages: impact on the ageing central nervous system","volume":"139","author":"Rawji","year":"2016","journal-title":"Brain : A Journal of Neurology"},{"key":"10.1016\/j.expneurol.2022.114195_bb0305","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fcell.2016.00047","article-title":"Regenerative capacity of macrophages for remyelination","volume":"4","author":"Rawji","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.expneurol.2022.114195_bb0310","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/glia.23135","article-title":"Microglial repopulation resolves inflammation and promotes brain recovery after injury","volume":"65","author":"Rice","year":"2017","journal-title":"Glia."},{"key":"10.1016\/j.expneurol.2022.114195_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2021.103590","article-title":"Macrophage roles in peripheral nervous system injury and pathology: allies in neuromuscular junction recovery","volume":"111","author":"Rios","year":"2021","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114195_bb0320","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.nbd.2016.05.014","article-title":"Progression of motor axon dysfunction and ectopic Na1.8 expression in a mouse model of Charcot-Marie-tooth disease 1B","volume":"93","author":"Rosberg","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2022.114195_bb0325","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1523\/JNEUROSCI.23-07-02833.2003","article-title":"The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy","volume":"23","author":"Samsam","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114195_bb0330","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ncl.2013.01.009","article-title":"Inherited peripheral neuropathies","volume":"31","author":"Saporta","year":"2013","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.expneurol.2022.114195_bb0335","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1523\/JNEUROSCI.20-02-00729.2000","article-title":"Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance","volume":"20","author":"Schmid","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114195_bb0340","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.cell.2016.01.032","article-title":"Axon degeneration gated by retrograde activation of somatic pro-apoptotic signaling","volume":"164","author":"Simon","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2022.114195_bb0345","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021857","article-title":"CSF-1 receptor signaling in myeloid cells","volume":"6","author":"Stanley","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0350","doi-asserted-by":"crossref","DOI":"10.1242\/dev.170316","article-title":"The regulation of the homeostasis and regeneration of peripheral nerve is distinct from the CNS and independent of a stem cell population","volume":"145","author":"Stierli","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.expneurol.2022.114195_bb0355","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1750-3639.1999.tb00229.x","article-title":"Nerve injury, axonal degeneration and neural regeneration: basic insights","volume":"9","author":"Stoll","year":"1999","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2022.114195_bb0360","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/s41467-020-16355-w","article-title":"Peripheral nerve resident macrophages share tissue-specific programming and features of activated microglia","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2022.114195_bb0365","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0896-6273(00)80177-4","article-title":"Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth 1B, Dejerine-Sottas, and congenital hypomyelination","volume":"17","author":"Warner","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2022.114195_bb0370","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41593-020-0618-6","article-title":"Profiling peripheral nerve macrophages reveals two macrophage subsets with distinct localization, transcriptome and response to injury","volume":"23","author":"Ydens","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114195_bb0375","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1523\/JNEUROSCI.3030-17.2018","article-title":"Macrophage depletion ameliorates peripheral neuropathy in aging mice","volume":"38","author":"Yuan","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114195_bb0380","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51796","article-title":"A MAC2-positive progenitor-like microglial population is resistant to CSF1R inhibition in adult mouse brain","volume":"9","author":"Zhan","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.expneurol.2022.114195_bb0385","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/(SICI)1097-4598(199608)19:8<946::AID-MUS2>3.0.CO;2-8","article-title":"Functional abnormalities in P0-deficient mice resemble human hereditary neuropathies linked to P0 gene mutations","volume":"19","author":"Zielasek","year":"1996","journal-title":"Muscle Nerve"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488622002205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488622002205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:55:11Z","timestamp":1762149311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488622002205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":76,"alternative-id":["S0014488622002205"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2022.114195","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presymptomatic macrophage targeting has a long-lasting therapeutic effect on treatment termination in a mouse model of Charcot-Marie-Tooth 1","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2022.114195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114195"}}